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E-mail address: rhsc1@cam.ac.uk (R.H.S. CarpenterDetailed measurements of saccadic latency – the time taken to make an eye movement to a suddenly- 
presented visual target – have proved a valuable source of detailed and quantitative information in a
wide range of neurological conditions, as well as shedding light on the mechanisms of decision, currently 
of intense interest to cognitive neuroscie ntists. However, there is no doubt that more complex oculomo- 
tor tasks, and in particular the antisaccade task in which a participant must make a saccade in the oppo- 
site direction to the target, are potentially more sensitive indicators of neurolo gical dysfunction,
particularly in neurodegenerative conditions. But two obstacles currently hinder their widespread adop- 
tion for this purpose. First, that much of the potential information from antisaccade experiments, notably 
about latency distribution and amplitude, is typically thrown away. Second, that there is no standardised 
protocol for carrying out antisaccade experiments, so that results from one laboratory cannot easily be
compared with those from another. This paper, the outcome of a recen t international meeting of oculo- 
motor scientists and clinicians with an unusually wide experience of such measure ments, sets out a pro- 
posed protocol for clinical antisaccade trials: its adoption will greatly enhance the clinical and scientiﬁc
beneﬁts of making these kinds of measure ments.
 2013 Elsevier Ltd. All rights reserved.1. Introduction 
Almost uniquely amongst clinical disciplines, neurology and 
psychiatry suffer from a lack of genuinely quantitative methods.
We cannot send to the lab for detailed blood counts, or precise 
measures of pulmonary function; with the exception of certain 
tests of peripheral nerve function, and of the sense organs, we oc- 
cupy, in effect, a number- free zone. To be sure, we have the rating 
scales used for Parkinson and Huntington patients, extensive ly
used in drugs trials: but they are subjective, and virtually impossi- 
ble to compare reliably from one clinic to another. And while our 
various kinds of brain scan are obviously clinically important in
localising the cerebral focus of certain kinds of disorders, and for 
evaluating progression in degenerative conditions, from a scientiﬁcll rights reserved.
).point of view they do not in themselves enlighten us much about 
function: where is not how . Progress in neurologi cal sciences re- 
quires quantitative methodologies .
One techniqu e that does yield numbers has been gaining in pop- 
ularity over the last decade: the measureme nt of eye movements.
In particular , a task that might at ﬁrst sight not seem very promis- 
ing is to present a subject with a visual target that jumps unexpect- 
edly from a central position a little to the right or left, and measure 
the time it takes a subject to make a an eye movement to the new 
target – the rapid conjugate response called a saccade. Though 
commonl y, and misleadingly, called ‘reﬂexive’, the long latency 
of the saccade in this step task – some 150–200 ms – reﬂects the 
fact that its initiation is the culminat ion of a prolonge d neural pro- 
cess of decision- making (Schall, 2003a ), a topic currently a focus of
intense interest amongst cognitive neuroscientists. Saccades are 
easy to elicit, measure and quantify, and amenable to the rigour 
of mathematical and computati onal approaches. With modern 
miniaturi sed and automated equipment, one can measure a couple 
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sively and without noticeable fatigue (since we normally make two 
or three saccades every second of our waking life anyway). Because 
saccades are largely automatic and stereotyped, the quantity of
data supplied by this kind of approach (which can be called saccad- 
ometry) can provide much information to the clinical neurologi st
(Leigh & Kennard, 2004 ). In addition, the functiona lity of the sacc- 
adic system is well understood and saccades have been divided 
into a recognisa ble hierarchy with speciﬁc physiologica l properties 
and anatomical substrates (Leigh & Zee, 2006 ).
In one respect saccades are not at all stereotyped: a feature of
saccadic latencies – indeed of all reaction times – is that however 
simple the stimulus or the task, they vary dramatically and ran- 
domly from one trial to the next, even when separated by only a
few seconds. The resultant statistical data concerning the distribu- 
tion of reaction time provide a wealth of precise informat ion about 
the underlying decision mechanisms, a window onto the operation 
of the very highest levels of cerebral function. Conseque ntly, mea- 
surements of saccadic latency distributions are increasingly being 
used by neuroscientists to study these mechanisms, and have re- 
sulted in quantitat ive models that can be used to summarise a sub- 
ject’s behaviour in ways that can be related to the underlying 
neural processes (Carpenter, Reddi, & Anderson, 2009; Carpenter 
& Williams, 1995; Gold & Shadlen, 2007; Noorani & Carpenter,
2011; Schall, 2003b; Shadlen & Gold, 2004 ). As a result, distribu- 
tional analysis of reaction time has also found an increasingly wide 
range of applications in clinical neurology: especiall y in neurode- 
generative diseases such as Parkinson’s and Huntington’s disease,
but also in a wide range of other conditions, from hepatic enceph- 
alopathy and phenylketon uria to migraine and frontotempor al
dementia (Antoniades et al., 2010; Burrell et al., 2012; Chandna 
et al., 2012; Dawson et al., 2011; Krismer et al., 2010; Michell 
et al., 2006; Perneczky et al., 2011; Temel, Visser-Vandewal le, &
Carpenter, 2008 ). The protocol is both simple and standardise d,
so data can be obtained under essentiall y identical conditions in
a clinic in San Francisco or a laboratory in Beijing.
However, there is one way in which this approach could be
made very much more effective. Although the step task can gener- 
ate highly signiﬁcant latency effects when analysed in this way,
they are often small: undoubtedly, more complex tasks can in
many cases be more sensitive indicators of pathological dysfunc- 
tion. Examples of such tasks include go/no-go (Noorani et al.,
2011), in which responses must be made to some stimuli and not 
others, countermand ing (Boucher et al., 2007; Emeric et al., 2007;
Hanes & Carpenter, 1999; Hanes & Schall, 1995 ), in which a de- 
layed stop signal tells the subject to withhold the response, and 
in particular antisaccad es (Butler et al., 2009; Condy et al., 2004;
Cutsuridis et al., 2007; Everling & Fischer, 1998; Feng, 2012;
Hutton & Ettinger, 2006; Katsanis et al., 1997; Kristjánsson,
2007; Peltsch et al., 2008; Pierrot-D eseilligny et al., 2002; Pouget 
et al., 2010; Smyrnis, 2008 ), in which the saccade must be made 
in a direction opposite to that of the stimulus. Speciﬁc deﬁcits in
antisaccades seem ﬁrst to have been noticed by Guitton, Buchtel,
and Douglas (1985), as a consequence of frontal lobe lesions.
A virtue of the antisaccade task is that it is cognitively demand- 
ing, so errors are made (a prosaccade to the target): consequentl y
there are two separate populations – the correct antisaccades 
and the incorrect prosaccades – from which latency and other sta- 
tistical measures can be obtained. It also lends itself to more com- 
plex tasks still, in which the subject must switch from one mode of
response to another (Cameron et al., 2010; Evens & Ludwig, 2010;
Olk & Jin, 2011 ). The growing importance of antisaccades in clinical 
investigatio n is reﬂected by an article and associated editorial that 
appeared while this paper was in the ﬁnal stages of preparation 
(Hellmuth et al., 2012; Kaufer, 2012 ), that underline the utility of
antisaccades in quantifyi ng the effects of both aging and neurolog- ical disease; their increasing use in psychiatr ic disorders has been 
the subject of another useful set of reviews (Gooding & Basso,
2008; Klein & Ettinger, 2008; Rommelse, van der Stigchel, &
Sergeant , 2008 ).
Unfortunate ly there are currently two major obstacles to a
wider adoption of the antisaccade in clinical practice. The ﬁrst is
that at present much of the kind of data that has proved so useful 
in saccadom etry is simply thrown away: a very large number of
studies report error rates and nothing else. It would therefore be
highly desirable to extend the saccadometric approach to antisac- 
cade tasks, by reporting full data about latency distribution s. Some 
have already started doing this (Cutsuridi s et al., 2007; Feng, 2012;
Meeter, van der Stigchel, & Theeuwes, 2010 ), and have also been 
developing quantitative models from which descriptive parame- 
ters could be extracted , in the way that has proved so useful for or- 
dinary saccadometr y using the step task, and could be related to
measure ments of brain activity (Papadopoul ou et al., 2010 ).
The second problem is that with a complex task of this kind, the
huge number of different possible protocols presents an embarras de
richesses: each investigator has their own favourite procedure, so
that even if more detailed data were to be published it would be dif-
ﬁcult to compare them. As a result, we ﬁnd large variations in ﬁnd-
ings across studies – even error rates vary from 2% to 30% (Smyrnis,
2008) – which are likely to be almost entirely due to differences of
protocol: indeed with sufﬁcient manipulation of the task it is possi-
ble to eliminate latency differences between pro- and antisaccades
completely (Chiau et al., 2011; Liu et al., 2010). Of course, in the
early, investigative, stages of research, it is essential that people do
things in different ways, and ﬁnd out which factors are important
and which are not. But once the technique has matured, and one
wants to apply it clinically as an actually useful test, it is clearly
essential that results can be compared from one lab to another.
Earlier this year, a small international meeting was held in Cam- 
bridge at which a number of people with an interest in facilitating 
this kind of co-opera tion met to see whether, despite the variety of
protocols currently in use, some agreement could be reached on a
common, harmonised protocol that could be recomme nded for use 
both as diagnostic aids and for scientiﬁc investigatio n. They were 
able to bring to the discussion a very wide range of experience of
measuring prosaccades as well as antisaccades , with a variety of
different protocols and techniqu es, and in a wide range of settings,
from specialised laboratories to ordinary clinics. One might have 
expected that individual experimenter s would be too ﬁrmly wed- 
ded to their particular procedures to be willing to change, but this 
proved not to be the case. Although the members of the committee 
came to the meeting with entirely different favourite ways of car- 
rying out these experiments, it soon became clear that these were 
not adopted because of passionatel y-held beliefs: with an ease that 
would not perhaps have been anticipat ed beforehand we arrived at
a general agreement for the standardise d protocol that follows.
2. The recommended protocol 
It may be helpful to present (Fig. 1) a generalised antisaccade 
task, and the notation we shall be using to refer to its components .
It can be seen that there are many potential parameters that need 
to be considered; fortunately they fall into four essentiall y inde- 
pendent categories :
1. Stimulus parameters , such as position and colour.
2. Trial parameters , that concern the timing of the stimuli to be
used in any particular trial.
3. Run parameters , to do with how individual trials are arranged 
into runs or blocks.
4. Outcome measures , the variables that are actually measured and 
reported.
Target
Pro (error)
Anti
G
FP
TD
TA
PA
AAAL
PL
Feedback?
PE
Curtail?
Fig. 1. Schematic representation of a generic antisaccade trial. Above (purple), step- 
like movement of the target from its initial ﬁxational position; below, a correct 
antisaccade (green) and incorrect prosaccade (red). FP = foreperiod; G = gap dura- 
tion; TA, TD = target amplitude and duration; PL, AL = pro- and antisaccade latency;
PA, AA = pro- and antisaccade amplitude; PE = proportion of error (prosaccade)
responses.
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making a particular recommendati on, and our ﬁnal conclusio n; we
start with the general guiding principles that informed our 
approach.2.1. General principles 
1. Timing. For clinical use, a paramount consideration is that the 
test should not be unduly tiring for the subject. We believe that 
it is appropriate to aim for a maximum duration of 20 min over- 
all, and that this requirement must constrain the choice of run 
and trial parameters.
2. Classes of stimuli . Whilst for scientiﬁc research much may be
learnt by using a variety of different stimulus types, given the 
time constraints in a clinical setting, we believe it is better to
get comprehens ive and good-quality data about one speciﬁc
stimulus, rather than poorer quality data about several.
3. Incidence of errors . Some have argued that it is desirable to use a
test that increases the average number of errors made. We
believe this view to be false: with a very difﬁcult task, an
impaired patient will produce a saturatingly (and thus uninfor- 
matively) large number of errors; conversel y, if the task is too 
easy, some may make very few errors indeed, so that the effects 
of therapeutic interventi on cannot be measure d. Either way, the 
potential amount of informat ion is limited. We therefore need a
task generating neither too few nor too many errors.
4. Prosaccades. Data should be obtained in the conventional pro- 
saccadic step task as well as in the antisaccad e task; the param- 
eters derived from the prosaccade task are helpful in trying to
model the antisaccades.
2.2. Stimulus parameters 
Direction. On the principle of reducing the number of classes of
stimuli, we recommend that only horizontally- arranged stimuli 
should be presented (they are in any case easier to record than 
vertical).
Amplitude. Similarly, we do not recommend using more than 
one target amplitud e (TA). Since amplitud es of less than 5 deg 
may be responsible for ‘square waves’ (see Leigh & Zee, 2006 ) in
some subjects, and amplitudes of more than 10 deg are accompa- 
nied by head movements under natural conditions, we recommend 
an amplitude of 8–10 deg, with stimuli presented in equal num- 
bers to left and right.Contrast. Targets should be of high contrast (>50%). If presented 
on a lab-based display, it is better practice for them to be dark on a
light background, so as to minimise issues related to light-adapta- 
tion level. If they are presented as laser projections, then the back- 
ground should be as uniform as possible and at the ordinary 
ambient level of illuminat ion, neither so bright as to reduce con- 
trast, nor so dark as to cause adaptation transient s. Size and shape 
of target are probably not very important: on screen displays we
recomme nd a diameter of 0.5 deg, but laser-projected targets of
much smaller diameter are also acceptab le, and may in fact be bet- 
ter from the point of view of discouraging microsaccades during 
the ﬁxation period.
2.3. Trial parameters 
The foreperiod FP during which the central ﬁxation target is dis- 
played should be of random duration in order to avoid temporal 
predictabi lity of peripheral target onset. Though it is not yet uni- 
versal practice, it was agreed that the duration should be non- 
ageing: that is, that the probability of it terminating per unit time 
should be constant (see for instance (Oswal, Ogden, & Carpenter,
2007). If this is not done, and the FP is ageing (in other words, uni- 
formaly distribut ed within its range), expectation rises steadily 
througho ut the foreperiod. Consequentl y in those trials for which 
the FP happens to be long the subject’s expectation of the target 
will be higher, and vice versa when it happens to be short, and 
these differences in expectati on will translate into an unwanted 
variabilit y of the reaction times and error rate. The random part 
of the foreperiod needs to be preceded by a component of ﬁxed
duration to ensure that subjects are never taken complete ly by sur- 
prise, and the non-ageing algorithm needs to be curtailed to avoid 
occasional extremely long durations: we recommend a total range 
of FP = 1–3.5 s, with a mean of 1.5 s.
Some experimenter s routinely use a gap (a small time interval,
often 100–200 ms, between central ﬁxation offset and target onset:
G in Fig. 1), which undoubtedly has an effect on subsequent behav- 
iour and may increase errors. Nevertheless, in the interest of sim- 
plicity and of reducing the time of each trial, we recommend that 
gaps are not used in routine clinical testing; thus G = 0.
There appears to be no evidence that target duration TD signiﬁ-
cantly affects performanc e. We recommend that the target should 
remain on for 1 s, which allows sufﬁcient time to record any cor- 
recting saccade if a prosaccade has been made.
Feedback has not been shown to inﬂuence performanc e, and 
should not be provided during a block, but given during the prac- 
tice runs (see below). However, if a subject makes four errors or
no-responses in a row in the antisaccad e task they should be re- 
minded of the task in order to ensure that they understand the 
instructions.
2.4. Run parameters 
Block size . Reliability of data appears to be high with blocks of
antisaccad e trials of around 45 trials for most subjects: we recom- 
mend a block size of 40 for antisaccades. Prosaccades are less 
fatiguing, and it was considered that 60 sequential prosaccade tri- 
als could be performed comfortably without signiﬁcant fatigue ef- 
fects. The aim here is to achieve an optimum trade-off between 
having enough trials to enable reliable and informative analysis,
and time and patient comfort.
Direction. Targets to the left and right should be randomly inter- 
leaved within a block. ‘Randomly’ with replacemen t (so that the 
expectati on of left and right before each trial is constant) or with- 
out replacement, so that the total frequenc y overall is identical. The 
former is probably to be preferred , but we are not aware of any evi- 
dence that it makes a signiﬁcant differenc e in runs of this length.
Target
Prosaccade
Curtail
Prosaccade task
Target
Prosaccade
Antisaccade
Curtail
Antisaccade task
60
prosaccades
60
prosaccades
40
antisaccades
40
antisaccades
40
antisaccades
1- minute
break
Fig. 2. Summary of the recommended protocol. Above, typical prosaccade (left) and antisaccade (right) trials. Below, the format of a single run.
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trials before the ﬁrst prosaccade block, and 4 before the ﬁrst anti- 
saccade block, those data being discarded, and feedback being pro- 
vided to the subject as necessar y.
It is important to give standardise d instructions to the subject,
pointing at the screen to emphasise the target positions and the 
correct responses. For the prosaccades, ‘Look at the central dot;
as soon as a new dot appears on the left or right, look at it as fast as
you can’. For the antisaccades: ‘Look at the central dot; as soon as
a new dot appears look in the opposite direction, to here, as fast 
as you can. You will probably sometimes make mistakes, and this is
perfectly normal .’ Note that we do not in general recommend asking 
the subjects to make ‘mirror’ saccades, i.e. to the exact opposite 
location on the display, since such an instruction is found not to af- 
fect the basic outcome measures of the task except the amplitud e
of the antisaccade (Evdokimidis, Tsekou, & Smyrnis, 2006 ), and 
may cause confusion. But if the amplitude is a desired outcome 
measure then the instruction should include the requiremen t for 
a mirror movement.
A suitable overall design, that starts with the simpler task and is
symmetrica l so that time-depend ent effects can be detected, is:
60 Prosaccades;40 antisaccades;40 antisaccades;40 antisaccades;
60 prosaccades :
There should be a break of 1 min between each block; with 
automated recording this total of 240 trials should take signiﬁ-
cantly less than the target of 20 min overall. This has been con- 
ﬁrmed in practice in preliminary trials in Oxford with 10 PD
patients and 10 age-matched controls: the subjects had no difﬁ-
culty in following the instructions, and the time for a complete 
protocol was between 13 and 16 min.
These recommendati ons are summarised in Fig. 2.2.5. Outcome measures 
The following parameters should be measured for each prosac- 
cade (control) trial:
1. Latency of ﬁrst saccade, from appearance of the target to the 
start of the saccade.
2. Whether in the correct direction, or no response at all, or a mis- 
recording (including blinks, head movements, etc.).
3. Peak saccadic velocity, if possible; duration might be added, but 
is perhaps less fundamental.4. The gain of the ﬁrst saccade (ratio of actual amplitude to correct 
amplitud e), if desired: this is probably better than simply 
recording amplitud e alone.
The following paramete rs should be recorded for each antisac- 
cade trial:
1. Latency of ﬁrst response, from appearance of the peripher al
stimulus to the start of the saccade.
2. Whether it was an anti- or prosaccade, a non-respon se, or a
mis-reco rding.
3. Latency of any correctin g saccade, measured from the end of the 
previous saccade (to count, a correctin g saccade must cross the 
midline).
4. Peak saccadic velocity of the ﬁrst response and of any correc- 
tion, if possible.
5. The gain of the ﬁrst saccade and of any correction, if desired.
Summary statistics to be reported should include cumulative 
distribut ions of control latencies, and of correct and error antisac- 
cade latencies ; it may be convenient to use reciprobit plots for 
this purpose, and to plot correct and error responses ‘defectively’,
i.e. as a cumulative proportion of the total number of trials (for an
example, see Noorani et al., 2011 ). When median values are used,
inter-qua rtile difference is more appropriate as a measure of
dispersio n than the standard deviation ; also the ratio of inter- 
quartile difference to the median (the coefﬁcient of variation) is
another measure of variation that is independen t of the central 
tendency of the distribution. All latencies greater than 50 ms
should be included, since distribut ions of early saccades can 
themselv es be of diagnostic or scientiﬁc signiﬁcance (Antoniad es
et al., 2010; Halliday & Carpenter , 2010 ). Total error rates in the 
antisaccad e task and median latencies in all tasks should be re- 
ported, as should mean peak velocity for each class of movement,
with standard deviations.
These outcome measures imply certain minimum technical 
requiremen ts for the recording and display equipment. For la- 
tency measure ments, 100 Hz sampling is a minimum, and a high- 
er rate may add a little to the precision (though this may not 
mean much, given the huge variability of the intertribal varia- 
tion): for peak saccadic velocity the requiremen t is higher, per- 
haps a band-width of 250 Hz, based on a higher raw sampling 
rate. If a conventi onal display screen is used, it should have a
frame rate of 100 Hz or more and be capable of synchronising 
with the oculometric data.
C. Antoniades et al. / Vision Research 84 (2013) 1–5 53. Conclusion 
We have presente d here a protocol for the clinical use of anti- 
saccades that is supported by a substantial number of practitioners 
in the ﬁeld, from a wide range of countries. We hope that its adop- 
tion will encourage clinicians to get more out of the data than at
present is commonly the case, that it will enable comparisons to
be made between different laborator ies and clinics, and – most 
important of all – between neurological and psychiatric conditions,
and that it will provide a basis for paramete risation of the data, as
has proved so successful for the simple saccadic step task.
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